NASDAQ:FBIOP Fortress Biotech (FBIOP) Stock Price, News & Analysis → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free FBIOP Stock Alerts $16.39 -0.11 (-0.67%) (As of 02:06 PM ET) Add Compare Share Share Today's Range$16.20▼$16.4950-Day Range$13.27▼$17.4352-Week Range$6.40▼$18.73Volume4,576 shsAverage Volume12,313 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield14.28%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Fortress Biotech alerts: Email Address Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" About Fortress Biotech Stock (NASDAQ:FBIOP)Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; Cosibelimab for metastatic cancers; Olafertinib for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and DFD-29 for the treatment of rosacea. The company's early stage product candidates include Dotinurad for gout; MB-106 for B-cell non-hodgkin lymphoma; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma; AJ201, an androgen receptor degradation enhancer; BAER-101, a positive allosteric modulator; MB-117 for newly diagnosed x-linked severe combined immunodeficiency; and MB217 for previously transplanted; and MB-110 for RAG1 severe combined immunodeficiency. Its preclinical product candidates comprise Mayo Clinic In Vivo CAR T Platform Technology; AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.Read More FBIOP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart FBIOP Stock News HeadlinesApril 23, 2024 | seekingalpha.comFBIOP Fortress Biotech, Inc. 9.375% CUM PFD AMarch 28, 2024 | investorplace.comFBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | finance.yahoo.comJourney Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsMarch 18, 2024 | finance.yahoo.comCheckpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of DirectorsMarch 15, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Fortress Biotech (FBIO) and Phreesia (PHR)February 22, 2024 | benzinga.comFortress Biotech Stock (NASDAQ:FBIO) Insider TradesFebruary 22, 2024 | benzinga.comFortress Biotech Stock (NASDAQ:FBIO), Short Interest ReportFebruary 17, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$3.06m On Fortress BiotechFebruary 13, 2024 | msn.comFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex dividend tomorrowFebruary 2, 2024 | stockhouse.comLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from SubsidiariesFebruary 2, 2024 | finance.yahoo.comLindsay Rosenwald’s Fortress Bio (NASDAQ: FBIO) Spotlight on 2024 Milestones from SubsidiariesJanuary 3, 2024 | finance.yahoo.comFortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 3, 2024 | sg.finance.yahoo.comFortress Biotech Inc (CNB1.SG)December 29, 2023 | markets.businessinsider.comNasdaq Down Over 100 Points; Fortress Biotech Shares PlummetDecember 29, 2023 | marketwatch.comFortress Biotech Shares Drop After Offering Gets PricedDecember 29, 2023 | msn.comFortress Biotech drops on plans to issue 3.3M sharesDecember 29, 2023 | markets.businessinsider.comFortress Biotech Announces Pricing Of Registered Direct Offering - Quick FactsDecember 13, 2023 | finance.yahoo.comAnalysts Expect Breakeven For Fortress Biotech, Inc. (NASDAQ:FBIO) Before LongDecember 7, 2023 | msn.comOrganovo, Fortress Biotech among healthcare moversNovember 28, 2023 | morningstar.comFortress Biotech Inc FBIONovember 16, 2023 | finance.yahoo.comInsider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires Shares ...November 15, 2023 | finanznachrichten.deFortress Biotech, Inc.: Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 15, 2023 | finanznachrichten.deFortress Biotech, Inc.: Fortress Biotech Announces Closing of $10.0 Million Public OfferingNovember 14, 2023 | finance.yahoo.comFortress Biotech Announces Closing of $10.0 Million Public OfferingNovember 14, 2023 | finance.yahoo.comMustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsSee More Headlines Receive FBIOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/30 Dividend4/12/2024Dividend Payable4/30/2024Ex-Dividend for 5/31 Dividend5/14/2024Today5/15/2024Dividend Payable5/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:FBIOP CUSIPN/A CIK1429260 Webwww.fortressbiotech.com Phone781-652-4500FaxN/AEmployees186Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$84.51 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Lindsay Allan Rosenwald (Age 69)Executive Chairman, President & CEO Comp: $212.66kMr. David Jin (Age 33)CFO & Head of Corporate Development Comp: $407.33kMr. Michael S. Weiss Esq. (Age 58)Executive Vice Chairman of Strategic Development & Director Comp: $182.66kMr. Samuel BerryGeneral Counsel & Corporate SecretaryDr. George C. Avgerinos (Age 70)Senior Vice President of Biologics Operations Comp: $386.49kKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAlpha Tau MedicalNASDAQ:DRTSWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWView All Competitors FBIOP Stock Analysis - Frequently Asked Questions How have FBIOP shares performed in 2024? Fortress Biotech's stock was trading at $11.87 at the beginning of 2024. Since then, FBIOP stock has increased by 36.5% and is now trading at $16.20. View the best growth stocks for 2024 here. How often does Fortress Biotech pay dividends? What is the dividend yield for Fortress Biotech? Fortress Biotech declared a monthly dividend on Sunday, May 5th. Stockholders of record on Wednesday, May 15th will be paid a dividend of $0.1953 per share on Friday, May 31st. This represents a $2.34 annualized dividend and a yield of 14.47%. The ex-dividend date is Tuesday, May 14th. Read our dividend analysis for FBIOP. Is Fortress Biotech a good dividend stock? Fortress Biotech (NASDAQ:FBIOP) pays an annual dividend of $2.34 per share and currently has a dividend yield of 12.11%. FBIOP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for FBIOP. How do I buy shares of Fortress Biotech? Shares of FBIOP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:FBIOP) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport Societyis this a buy and hold stock?Tips4TradersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving TrendsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.